Navigation Links
DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008
Date:3/16/2009

D, Mr. Wilke will be integrally involved in the development of the DATATRAK eClinical platform. Mr. Wilke originally joined DATATRAK in February 2006 as part of the ClickFind acquisition and left the Company in August 2008.

DATATRAK's backlog at December 31, 2008 was $11.4 million and backlog currently stands at approximately $10.1 million. This compares to a backlog of $13.0 million at December 31, 2007. Backlog is defined as the remaining value of signed contracts or authorization letters to commence services. The Company does not include in its backlog potential contracts or authorization letters that have passed the verbal stage, but have not been signed. All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.

The Company, in compliance with NASDAQ Marketplace Rule 4350(b)(1)(B), also announced that the audit report included in DATATRAK's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 expresses an unqualified opinion from its independent registered public accounting firm, Ernst & Young, LLP, but contains an explanatory paragraph relating to the Company's ability to continue as a going concern. The Company discusses the matter further in its Form 10-K, which will be filed later today.

"In 2008, we implemented and largely completed a substantial reorganization and right-sizing initiative, and as a result, we believe we are well positioned to withstand the increasingly difficult operating environment. The impact of these changes aided in our ability to maintain a small operating loss of only $109,000 in the fourth quarter of 2008 versus an operating loss of $2.6 million in last year's f
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. DATATRAK International, Inc. Announces the Return of Chris Wilke as Vice-President of R&D and the Issuance of a Patent
2. DATATRAK Announces Retirement of Chief Executive Officer
3. DATATRAK International, Inc. Receives Notice from NASDAQ
4. NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan
5. DATATRAK International, Inc. Announces 2008 Third Quarter and Nine Month Operating Results
6. DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008
7. DATATRAK International, Inc. Receives Notice From Nasdaq
8. Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies
9. DATATRAK Announces Restructured Senior Management Team
10. DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
11. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...areandCalgaryScientificInc.,aleadingproviderofsoft...ofAegis(TM)Breast4DAdvancedVisualizationsoftware. ...ootprintWebclientbasedmedicalimagingofferinginthem...forzero-footprintaccess-requiringnosoftwaredownloa...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...vaccine carried into the body on a carefully engin...ccessfully eliminate tumors in mammals, scientists...ional Medicine . , The new approach, pioneered b...sity, uses plastic disks impregnated with tumor-sp...program the mammalian immune system to attack tumo...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
.... scientists discover an effective method of vacci...ium Yersinia pestis//, with the details of their s...ture Immunology. Egil Lien and his colleagues a...fatty sugars in the development of an effective va...
... Waters’ missionary work to spread the Gospel to f...ecades, but it left his head pounding.// Begi...t eventually forced him to return home. Medi... caused facial throbbing, until he came to the Eug...
... blame yourself, if your taste buds get tickled at...re mention! A recent investigation into the reaso...arian food has shown that such tendencies are gene...be in the pink of health. To understand such incli...
...rotein helps lower total cholesterol, low-density ...ghtly raises high-density lipid “good” cholesterol...ed in the Sept. 1, 2006 issue of The American Jour...or the prevention and treatment of high blood chol...
...ent study reveals that short sessions (a few minut... same results as moderate exercises done for hours...inesiology at McMaster University and his team con...g finding from our study was the remarkably simila...
...to - Those Canadians who live in far-flung areas r...to the city-dwellers, primarily due to an increase...idental injury, as stated by a report released by ...nt in the god-forsaken areas of rural Canada, in s...
Other Medicine News:Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 2Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 3Health News:Rural Canadians, Take Care Of Your Health 2
(Date:11/25/2009).../PRNewswire-FirstCall/--HeskaCorporation(HSKA);("H...ecialtyproductstotheveterinaryindustry,announcedto...supplyofbloodgasproductsandaffiliatedconsumablesfo...com.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "H...ieldofadvancedpoint-of-carediagnostics,"commentedM...
(Date:11/25/2009)...wswire/--BioTrendsResearchGroup,Inc.releasedWave1o...tinamulti-phasesyndicatedmarketresearchprojecttrac...productlaunchthroughthefirstsixmonthsofavailabilit...onfrom75uniqueDermatologistsandqualitativeinformat...elara,obstaclestouse,typicalpatienttypes,productpe...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Herley Reports Fourth Quarter and Year End Results 59611 1Herley Reports Fourth Quarter and Year End Results 59611 2Herley Reports Fourth Quarter and Year End Results 59611 3Herley Reports Fourth Quarter and Year End Results 59611 4Herley Reports Fourth Quarter and Year End Results 59611 5Herley Reports Fourth Quarter and Year End Results 59611 6Herley Reports Fourth Quarter and Year End Results 59611 7Herley Reports Fourth Quarter and Year End Results 59611 8Herley Reports Fourth Quarter and Year End Results 59611 9Herley Reports Fourth Quarter and Year End Results 59611 10Herley Reports Fourth Quarter and Year End Results 59611 11Herley Reports Fourth Quarter and Year End Results 59611 12Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Scientists use math modeling to predict unknown biological mechanism of regulation 14500 1Scientists use math modeling to predict unknown biological mechanism of regulation 14500 2
...ermanent version of the glasses ...vative prism glasses can,significantly improve the...nopia, a condition that blinds half the visual fie...ch were invented by Dr. Eli Peli, a Senior,Scienti...ted in the first,community-based multi- center tri...
...utics, Inc.,announced the successful completion of...nd, VEL-0230, which the company is investigating a...her bone diseases. In,extensive preclinical studie...ory agent that also stimulates bone formation and ...ristics strongly suggest this drug,may be an impor...
Other Medicine Technology:Prism Glasses Expand the View for Patients with Hemianopia 2Prism Glasses Expand the View for Patients with Hemianopia 3Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2
LD Lactate –> Pyruvate
Rheumatoid Factor Latex Test (RF)
IgG (sample dilution, 1-shot only) (Liquid)
CRP (Complete Kit with Disposible Cards)
Medicine Products: